1. 2025
  2. Dexamethasone Reduces Cytokine mRNA Levels and Microglial Activity in the Brainstem of Newborn Rats

    Kalinina, T. S., Bulygina, V. V., Lanshakov, D. A., Sukhareva, E. V. & Dygalo, N. N., 18 Mar 2025, In: Neurochemical Journal. 18, 4, p. 643-648 6 p.

    Research output: Contribution to journalArticlepeer-review

  3. 2024
  4. Brainstem transcriptomic changes in male Wistar rats after acute stress, comparing the use of duplex specific nuclease (DSN)

    Lanshakov, D. A., Sukhareva, E. V., Bulygina, V. V., Khozyainova, A. A., Gerashchenko, T. S., Denisov, E. V. & Kalinina, T. S., Dec 2024, In: Scientific Reports. 14, 1, 25 p., 21856.

    Research output: Contribution to journalArticlepeer-review

  5. 2021
  6. Single neonatal dexamethasone administration has long-lasting outcome on depressive-like behaviour, Bdnf, Nt-3, p75ngfr and sorting receptors (SorCS1-3) stress reactive expression

    Lanshakov, D. A., Sukhareva, E. V., Bulygina, V. V., Bannova, A. V., Shaburova, E. V. & Kalinina, T. S., 14 Apr 2021, In: Scientific Reports. 11, 1, 13 p., 8092.

    Research output: Contribution to journalArticlepeer-review

  7. Роль кортикотропин-рилизинг гормона и его рецепторов в регуляции нейрофизиологических и поведенческих реакций на стресс

    Sukhareva, E. V., Mar 2021, In: Vavilovskii Zhurnal Genetiki i Selektsii. 25, 2, p. 216-223 8 p., 10.

    Research output: Contribution to journalReview articlepeer-review

  8. 2020
  9. The relationship between the noradrenergic system activity and the expression of cytokines in the neonatal rat brain

    Kalinina, T., Bulygina, V., Egorova, K., Sukhareva, E. & Dygalo, N., Nov 2020, In: European Neuropsychopharmacology. 40, p. S55-S56 2 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  10. Chemogenetic Activation of Glutamatergic Neurons in the Juvenile Rat Cortex Reduces Anxiety

    Dygalo, N. N., Lanshakov, D. A., Komysheva, N. P., Drozd, U. S., Shaburova, E. V., Sukhareva, E. V. & Shishkina, G. T., 1 Jan 2020, In: Doklady Biochemistry and Biophysics. 490, 1, p. 16-18 3 p., 5.

    Research output: Contribution to journalArticlepeer-review

  11. 2019
  12. Extrahypothalamic CRH and its receptors change tyrosine hydroxylase expression after neonatal dexamethasone treatment

    Sukhareva, E. V., Lanshakov, D., Kalinina, T., Bulygina, V. & Dygalo, N., Dec 2019, In: European Neuropsychopharmacology. 29, p. S301-S302 2 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  13. Long-term up-regulation of tyrosine hydroxylase gene expression after neonatal dexamethasone

    Kalinina, T., Sukhareva, E., Bulygina, V., Lanshakov, D., Egorova, K. & Dygalo, N., Dec 2019, In: European Neuropsychopharmacology. 29, p. S166-S167 6 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  14. Subanesthetic dose of ketamine relieves depression-like behavior induced by optogenetic stimulation of the hippocampal pyramidal neurons

    Dygalo, N., Drozd, U. S., Kalinina, T. S., Sukhareva, E. V., Bulygina, V. V., Shishkina, G. T. & Lanshakov, D. A., Dec 2019, In: European Neuropsychopharmacology. 29, p. S94-S94 1 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  15. Ketamine improves depressive symptoms caused by stress and induces c-Fos expression in the brain resembling some effects of stress

    Dygalo, N., Drozd, U. S., Kalinina, T. S., Sukhareva, E. V., Bulygina, V. V., Shishkina, G. T. & Lanshakov, D. A., 2019, In: European Neuropsychopharmacology. 29, p. S212-S212 1 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

Previous 1 2 Next

ID: 3437341